We observed that IGF1R, MXI1, PPARA, YWHAZ, and MAPK9 were remarkably strongly correlated with pathologic progression in AD and may function as facilitators or inhibitors of AD. This evidence concerns the gene MAPK9 and Alzheimer disease.